No Association Between Single Nucleotide Polymorphisms and the Development of Nephrotoxicity After Orthotopic Heart Transplantation

Journal of Heart and Lung Transplantation

Volumn 27, Issue 7, 2008, Pages 741-745

  Klauke, Bärbel ^a   Wirth, Andreas ^a   Zittermann, Armin ^a   Bohms, Birte ^a   Tenderich, Gero ^a   Körfer, Reiner ^a   Milting, Hendrik ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; CYTOCHROME P450 3A5; IMMUNOSUPPRESSIVE AGENT; MULTIDRUG RESISTANCE PROTEIN 1; TACROLIMUS; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; GENE SEQUENCE; GENETIC VARIABILITY; GLOMERULUS FILTRATION RATE; HEART TRANSPLANTATION; HEREDITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; NEPHROTOXICITY; ORTHOTOPIC TRANSPLANTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; CASE-CONTROL STUDIES; CYCLOSPORINE; CYTOCHROME P-450 CYP3A; FEMALE; GENOTYPE; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; P-GLYCOPROTEIN; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; RENAL INSUFFICIENCY; TACROLIMUS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 45549096335     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2008.04.001     Document Type: Article

References (21)

1. Bloom R.D., and Doyle A.M. Kidney disease after heart and lung transplantation. Am J Transplant 6 (2006) 671-679
2. Taylor D.O., Edwards L.B., Boucek M.M., et al. Registry of the International Society for Heart and Lung Transplantation: twenty-second official adult heart transplant report-2005. J Heart Lung Transplant 24 (2005) 945-955
3. Tambur A.R., Pamboukian S., Costanzo M.R., et al. Genetic polymorphism in platelet-derived growth factor and vascular endothelial growth factor are significantly associated with cardiac allograft vasculopathy. J Heart Lung Transplant 25 (2006) 690-698
4. Thervet E., Anglicheau D., King B., et al. Impact of cytochrome p450 3A5 genetic polymorphism on tacrolimus doses and concentration-to-dose ratio in renal transplant recipients. Transplantation 76 (2003) 1233-1235
5. Kalow W., Tang B.K., and Endrenyi L. Hypothesis: comparisons of inter- and intra-individual variations can substitute for twin studies in drug research. Pharmacogenetics 8 (1998) 283-289
6. Anglicheau D., Legendre C., and Thervet E. Pharmacogenetics in solid organ transplantation: present knowledge and future perspectives. Transplantation 78 (2004) 311-315
7. Lindahl G.E., Chambers R.C., Papakrivopoulou J., et al. Activation of fibroblast procollagen alpha 1(I) transcription by mechanical strain is transforming growth factor-beta-dependent and involves increased binding of CCAAT-binding factor (CBF/NF-Y) at the proximal promoter. J Biol Chem 277 (2002) 6153-6161
8. Kitamura M., and Suto T. TGF-beta and glomerulonephritis: anti-inflammatory versus prosclerotic actions. Nephrol Dial Transplant 12 (1997) 669-679
9. Chowbay B., Cumaraswamy S., Cheung Y., Zhou Q., and Lee E. Genetic polymorphisms in MDR1 and CYP3A4 genes in Asians and the influence of MDR1 haplotypes on cyclosporin disposition in heart transplant recipients. Pharmacogenetics 13 (2003) 89-95
10. Anglicheau D., Verstuyft C., Laurent-Puig P., et al. Association of the multidrug resistance-1 gene single-nucleotide polymorphisms with the tacrolimus dose requirements in renal transplant recipients. J Am Soc Nephrol 14 (2003) 1889-1896
11. Zheng H., Webber S., Zeevi A., et al. Tacrolimus dosing in pediatric heart transplant patients is related to CYP3A5 and MDR1 gene polymorphisms. Am J Transplant 3 (2003) 477-483
12. Yamauchi A., Ieiri I., Kataoka Y., et al. Neurotoxicity induced by tacrolimus after liver transplantation: relation to genetic polymorphisms of the ABCB1 (MDR1) gene. Transplantation 74 (2002) 571-572
13. Baan C.C., Balk A.H., Holweg C.T., et al. Renal failure after clinical heart transplantation is associated with the TGF-beta 1 codon 10 gene polymorphism. J Heart Lung Transplant 19 (2000) 866-872
14. Lacha J., Hubacek J.A., Viklicky O., et al. TGF-beta1 gene polymorphism is a risk factor for renal dysfunction in heart transplant recipients. Transplant Proc 33 (2001) 1567-1569
15. Milting H., Lukas N., Klauke B., et al. Composite polymorphisms in the ryanodine receptor 2 gene associated with arrhythmogenic right ventricular cardiomyopathy. Cardiovasc Res 71 (2006) 496-505
16. Saeki T., Ueda K., Tanigawara Y., Hori R., and Komano T. Human P-glycoprotein transports cyclosporin A and FK506. J Biol Chem 268 (1993) 6077-6080
17. Kim R., Leake B., Choo E., et al. Identification of functionally variant MDR1 alleles among European Americans and African Americans. Clin Pharmacol Ther 70 (2001) 189-199
18. Hebert M.F., Dowling A.L., Gierwatowski C., et al. Association between ABCB1 (multidrug resistance transporter) genotype and post-liver transplantation renal dysfunction in patients receiving calcineurin inhibitors. Pharmacogenetics 13 (2003) 661-674
19. Kuehl P., Zhang J., Lin Y., et al. Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression. Nat Genet 27 (2001) 383-391
20. Grinyo J., and Cruzado J. Cyclosporine nephrotoxicity. Transplant Proc 36 suppl (2004) 240S-2
21. Brogan I.J., Pravica V., and Hutchinson I.V. Genetic conservation of the immunophilin-binding domains of human calcineurin A1 and A2. Transplant Immunol 8 (2000) 139-141